Homepage

Heart failure patient receives care from his doctor

Heart failure: dealing with one of the world's biggest killers

Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.

Bodypainter Natalie Fletcher paints on model

Stories / Education & Awareness

Body painter captures anguish of those who suffer from psoriasis

To understand the impact of psoriasis on those who live with it, we helped organize a global survey...

NIBR researcher Jennifer Allport-Anderson looks into a microscope

Stories / Discovery

A cellular drama at the heart of a researcher’s family

Jennifer Allport-Anderson hunts for cardiac cures.

Explore Novartis

Corporate Responsibility

Research & Development

Clinical Pipeline

Recent Updates

Novartis BioCamp 2013, International BioCamp, International Biotechnology Leadership Camp, science education, future of healthcare, commitment to research

Featured / Aug 26

Students take on the challenges of digital medicine

Novartis BioCamp gives students new perspectives on healthcare challenges.

Media Release / Sep 28

Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges

Media Release / Sep 22

Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs

Media Release / Sep 15

Novartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress

On #WorldHeartDay (9/29), #RiseAboveHF w/ us, @American_Heart, @IAMQUEENLATIFAH & #heartfailure experts. Live on: https://t.co/BbAkrXaDt9 19 hours 13 min ago

Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.